新药临床试验期间药物警戒和风险控制研究一:欧美新药临床试验期间药物警戒体系要求对我国申办者的启示
智会静, 冯红云, 周凌芸, 杨建红, 吕心欢, 黎泽琳, 李浩
中国药事 ›› 2022, Vol. 36 ›› Issue (6) : 616-623.
新药临床试验期间药物警戒和风险控制研究一:欧美新药临床试验期间药物警戒体系要求对我国申办者的启示
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Research I on Pharmacovigilance and Risk Control During Clinical Trials of New Drugs: The Enlightenment of the Requirements for Pharmacovigilance System in Europe and US to Chinese Sponsors
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
